Patent · US Active

Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists

US10030025B2 · kind B2 · utility

1Cited by

6References

19Claims

0Family size

Assignee

Ogeda SA · BE

Inventors

Hamid R. Hoveyda · Brussels, BE
Guillaume Dutheuil · Vedrin, BE
Graeme L. Fraser · Bousval, BE

Key dates

Filing date	Jul 8, 2016
Grant date	Jul 24, 2018
Priority date	—
Expiry date	Jul 8, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel compounds of Formula I and their use in therapeutic treatments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.